查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1450316

遺傳性聽力損失市場：現況分析與預測（2023-2030）

Hereditary Deafness Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於聽力損失治療方法的不斷發展，遺傳性聽力損失市場預計將以約 5.1% 的穩定速度成長。例如，哈佛醫學院的研究人員於2024 年1 月在中國復旦進行的一項研究顯示，6 名1 歲至7 歲患有遺傳性聽力損失的兒童接受了基因治療，這6 名患者中有5名接受了基因治療。在預測期內，有幾個因素正在推動市場成長，包括聽力損失發生率的急劇增加、對遺傳性聽力損失的認識不斷提高以及耳鼻喉科投資的增加。除此之外，遺傳性聽損治療效率的加速帶來了有效的治療程序，也穩定地推動了遺傳性聽損市場的發展。

根據診斷類型，市場分為物理測試、分子遺傳學測試等。由於遺傳性聽力損失診斷需求不斷增加，2022年體檢細分市場將在全球遺傳性聽力損失市場中佔據最大佔有率。身體檢查對於識別外耳異常、中耳病變和其他可能導致遺傳性聽力損失的結構異常至關重要。此外，身體檢查還可以評估整體健康狀況，識別與特定基因突變相關的症狀特徵，並指導進一步的診斷測試。因此，在診斷類型中，體檢領域在2022年佔據了重要的市場佔有率。

根據治療類型，市場分為助聽器、人工耳蝸等。由於產品創新和批准的增加，預計人工耳蝸細分市場將在預測期內佔據重要佔有率。例如，2023 年 12 月，人工耳蝸技術供應商 Advanced Bionics 的人工耳蝸聲音處理器產品 Marvel CI 獲得 FDA 批准，宣佈擴大聽力保健服務和患者治療效果。人工耳蝸是一種電子設備，可以為無法從助聽器中受益的重度至極重度聽力損失的人提供聲音的感覺。人工耳蝸由放置在耳後的外部處理器和透過手術植入皮下的內部組件組成。人工耳蝸可以顯著改善許多患有嚴重聽力損失的人的言語感知和溝通能力。因此，在預測期內，人工耳蝸類別預計將在治療類型中表現出更高的複合年增長率。

為了更瞭解遺傳性聽力損失的市場介紹，市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區）、亞太地區（中國） 、日本、印度、亞太地區其他地區）及世界其他地區。由於遺傳性聽力損失病例的迅速增加、人們對遺傳性聽力損失的認識不斷提高以及對引進創新耳鼻喉科治療的投資不斷增加，北美在 2022 年的當前情景中佔據主導地位。例如，根據美國衛生與公眾服務部的數據，美國每 1,000 名兒童中約有 2 至 3 名出生時一隻或雙耳患有可檢測到的聽力損失。政府機構正在啟動遺傳性聽力損失意識計劃，以幫助該地區越來越多的聽力損失患者。因此，2022年北美將佔據很大的市場佔有率。

目錄

第一章 市場介紹

  • 市場定義
  • 主要目標
  • 利益相關者
  • 限制

第二章 研究方法或前提條件

  • 調查過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第五章 COVID-19 對遺傳性聽力損失市場的影響

第六章 遺傳性聽損市場收入，2020-2030

第七章市場洞察：依診斷類型

  • 體檢
  • 分子遺傳學檢測
  • 其他

第 8 章市場洞察：依治療類型

  • 助聽器
    • 耳背式助聽器
    • ITE助聽器
    • ITC助聽器
    • 其他
  • 人工耳蝸
  • 其他

第9章市場洞察：依地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 世界其他地區

第10章遺傳性聽損市場動態

  • 市場驅動力
  • 市場課題
  • 影響分析

第十一章遺傳性聽損市場機會

第十二章遺傳性聽損市場趨勢

第十三章需求面與供給面分析

  • 需求面分析
  • 供給側分析

第十四章價值鏈分析

第15章 競爭場景

  • 競爭格局
    • 波特五力分析

第十六章公司簡介

  • Cochlear Ltd.
  • Envoy Medical
  • Advanced Bionics AG and affiliates
  • Zhejiang Nuoerkang Neuroelectronics Technology Co., Ltd.
  • Oticon Medical A/S
  • Medtronic
  • Sonova
  • Audina Hearing Instruments, Inc.
  • RION Co., Ltd.
  • GN Store Nord A/S

第十七章 免責聲明

簡介目錄
Product Code: UMHE212650

Hereditary deafness refers to hearing loss that is passed down through generations within a family due to genetic factors. It can be caused by mutations in various genes involved in the development or function of the auditory system. Depending on the specific genetic mutation, hereditary deafness can be present at birth or develop later in life. Innovations in treatment options, which may include hearing aids and cochlear implants are leading to the growth of the market. Several other factors, such as rising research & development activities, rising healthcare expenditure, rising regulatory support, and a surge in government collaborations & partnerships are leading drivers of hereditary deafness globally.

The Hereditary Deafness Market is expected to grow at a steady rate of around 5.1% owing to the rising therapeutic developments for treating deafness. For instance, in January 2024, a research conducted in Fudan, China with Harvard Medical School researchers treated six children between the ages of one to seven suffering from a type of inherited deafness through gene therapy, in which five of the six children showed signs of improved hearing. Several factors, including a surge in the incidence of hearing loss, increasing awareness regarding hereditary deafness, and increased investments in otolaryngology departments are driving the market's growth during the forecast period. Apart from this, accelerated treatment efficiency with hereditary deafness has resulted in effective treatment procedures which are also driving this market of hereditary deafness at a steady rate.

Based on the diagnosis type, the market is segmented into physical examination, molecular genetic testing, and others. The physical examination segment held the maximum share in the global market of hereditary deafness in 2022 owing to the rising demand for hereditary deafness diagnostics. Physical examinations are essential for identifying external ear anomalies, middle ear pathologies, and other structural abnormalities that may contribute to hereditary deafness. Additionally, physical examinations can help assess overall health status, identify syndromic features associated with certain genetic mutations, and guide further diagnostic investigations. Thus, among the diagnosis types, the physical examination segment held a significant market share in 2022.

Based on treatment type, the market is categorized into hearing aids, cochlear implants, and others. The cochlear implants segment is expected to hold a significant share of the market in the forecast period owing to the rising product innovations and approvals. For instance, in December 2023, Advanced Bionics, a provider of cochlear implant technology, received FDA approval and announced the expansion of its cochlear implant sound processor product, Marvel CI, and feature offerings to improve hearing care delivery and patient outcomes. Cochlear implants are electronic devices that can provide a sense of sound to individuals with severe to profound hearing loss who do not benefit from hearing aids. They consist of an external processor worn behind the ear and an internal component surgically implanted under the skin. Cochlear implants can significantly improve speech perception and communication abilities in many people with severe hearing loss. Thus, the cochlear implants category is expected to witness a higher CAGR amongst treatment types during the forecast period.

For a better understanding of the market adoption of hereditary deafness, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the surge in cases of hereditary deafness, rising awareness about hereditary deafness, and the rising number of investments in introducing innovative otolaryngology therapies. For instance, according to the U.S. Department of Health and Human Services, about 2 to 3 out of every 1,000 children in the U.S. are born with a detectable level of hearing loss in one or both ears. Government organizations are initiating hereditary deafness awareness programs for the sake of the growing deafness cases in the region. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include Cochlear Ltd; Envoy Medical; Advanced Bionics AG and affiliates; Zhejiang Nuoerkang Neuroelectronics Technology Co., Ltd.; Oticon Medical A/S; Medtronic; Sonova; Audina Hearing Instruments, Inc.; RION Co., Ltd.; GN Store Nord A/S.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

  • 1.1.Market Definitions
  • 1.2.Main Objective
  • 1.3.Stakeholders
  • 1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.Research Process of the Hereditary Deafness Market
  • 2.2.Research Methodology of the Hereditary Deafness Market
  • 2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE HEREDITARY DEAFNESS MARKET

6. HEREDITARY DEAFNESS MARKET REVENUE (USD BN), 2020-2030F

7. MARKET INSIGHTS BY DIAGNOSIS TYPE

  • 7.1.Physical Examination
  • 7.2.Molecular Genetic Testing
  • 7.3.Others

8. MARKET INSIGHTS BY TREATMENT TYPE

  • 8.1.Hearing Aids
    • 8.1.1.Behind-The-Ear Hearing Aids
    • 8.1.2.In-The-Ear Hearing Aids
    • 8.1.3.In-The-Canal Hearing Aids
    • 8.1.4.Others
  • 8.2.Cochlear Implants
  • 8.3.Others

9. MARKET INSIGHTS BY REGION

  • 9.1.North America
    • 9.1.1.U.S.
    • 9.1.2.Canada
    • 9.1.3.Rest of North America
  • 9.2.Europe
    • 9.2.1.Germany
    • 9.2.2.U.K.
    • 9.2.3.France
    • 9.2.4.Italy
    • 9.2.5.Spain
    • 9.2.6.Rest of Europe
  • 9.3.Asia-Pacific
    • 9.3.1.China
    • 9.3.2.Japan
    • 9.3.3.India
    • 9.3.4.Rest of Asia-Pacific
  • 9.4.Rest of World

10. HEREDITARY DEAFNESS MARKET DYNAMICS

  • 10.1.Market Drivers
  • 10.2.Market Challenges
  • 10.3.Impact Analysis

11. HEREDITARY DEAFNESS MARKET OPPORTUNITIES

12. HEREDITARY DEAFNESS MARKET TRENDS

13. DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1.Demand Side Analysis
  • 13.2.Supply Side Analysis

14. VALUE CHAIN ANALYSIS

15. COMPETITIVE SCENARIO

  • 15.1.Competitive Landscape
    • 15.1.1.Porters Fiver Forces Analysis

16. COMPANY PROFILED

  • 16.1.Cochlear Ltd.
  • 16.2.Envoy Medical
  • 16.3.Advanced Bionics AG and affiliates
  • 16.4.Zhejiang Nuoerkang Neuroelectronics Technology Co., Ltd.
  • 16.5.Oticon Medical A/S
  • 16.6.Medtronic
  • 16.7.Sonova
  • 16.8.Audina Hearing Instruments, Inc.
  • 16.9.RION Co., Ltd.
  • 16.10.GN Store Nord A/S

17. DISCLAIMER